Uncategorized
Uncategorized · page 7
- CBD Market
French CBD Industry Under Attack From Food Regulators
THE latest move by the French authorities to undermine the country’s thriving CBD industry will be met with widespread resistance, say the industry’s leading trade bodies.
- Uncategorized
Can You Trust a Review? Patient Feedback in the Medical Cannabis Sector
As the medical cannabis sector matures, patient feedback is playing an increasingly important role in shaping market dynamics and building trust when it comes to choosing the right clinic.
- Uncategorized
Arizona Moves Ahead With Intoxicating Hemp Ban, Retailers Now Face $20k Fines Per Product
Intoxicating hemp product sellers in Arizona could now face criminal charges, raids and fines as a Country Court Judge ruled to dismiss a temporary restraining order from industry representatives.
- Uncategorized
Tilray & Flora Growth Target Stock Consolidation as Values Continue Decline, Chill Brands Raises £1m From Major Shareholder
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The international cannabis giant has announced plans to issue a ‘reverse stock split’, an increasingly common tool in the cannabis industry to artificially inflate stock prices.
- Uncategorized
Legal Challenge Over DEA’s Handling of Cannabis Rescheduling Dropped, Removing 1 Barrier Preventing Progress
A coalition of pro-cannabis medical professionals has dropped its lawsuit against the Drug Enforcement Administration (DEA), clearing one of the many hurdles preventing the process from progressing.
- Uncategorized
Two Federal Cannabis Reform Bills Set to Transform Regulation Across US Introduced
Two separate bipartisan cannabis reform bills that, if passed, would transform US cannabis regulation across the country.
- Uncategorized
CB21 Pharma Successfully Passes Certification Audit for Dronabinol Manufacturing
CB21 Pharma, a leading pharmaceutical company focused on developing and marketing innovative cannabinoid-based treatments, is pleased to announce the successful completion of its certification audit for manufacturing plant-derived Dronabinol by the State Institute for Drug Control (SÚKL).
- Uncategorized
Dalgety Doubles Down on UK-Grown Cannabis With Three New Strains and £8M Expansion Drive
Having done the legwork over the last five years to build a state-of-the-art 30,000sq ft indoor growing facility, and secure licencing to cultivate, manufacture and supply medical cannabis flower from its facility, Dalgety is wasting no time in ramping up its operations.
- Uncategorized
New Hampshire Committee Recommends Rejection of Cannabis Legalization Bill, But Hope Remains for Full Senate Vote
New Hampshire’s Senate Judiciary Committee has voted to recommend against a bipartisan bill to legalize possession of cannabis for adults, but there is still hope for the bill in a full Senate floor vote.
- Uncategorized
Ananda Lists on US OTCQB Market, Argent Bio Signs Data Sharing Deal With AusCann, & IMC Under New Threat of NASDAQ Delisting
Ananda Pharma [stock_market_widget type=”chart” template=”line” assets=”ANANF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks Ananda has announced its entrance onto the US OTCQB Exchange, opening up its stock to US investors.
- Uncategorized
How a Colorado Operator Stumbled Onto ‘Blueprint for Laundering Marijuana’
The CEO Mammoth Farms stumbled onto ‘the blueprint for how to launder marijuana’ in and out of the state’s regulated industry, he told MJBizDaily.
- Uncategorized
Public Money May Have Helped Defeat Florida’s Cannabis Legalization Ballot
Florida Governor Ron Desantis and his wife are coming under increasing scrutiny over their apparent use of millions in public settlement funds to bankroll a critical anti-cannabis legalization campaign.
